1. The FDA requires that patient (or parent) consent be given before patients are enrolled in clinical trials, no matter where in the world the trials are conducted. Sometimes such consent cannot be easily obtained due to language barriers or literacy problems (meaning the parents can’t read and/or sign consent). Should the trials proceed anyway if there is a chance of benefit to the children?